Lexaria Bioscience (LEXX) Gross Margin Growth (1y) (2018 - 2026)
Lexaria Bioscience (LEXX) Gross Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -93.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -91.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 210.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1,966.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 228.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -475.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,672.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1,034.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Lexaria Bioscience | 10.15 Mn | 6.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 0.00 |
| Aug 31, 2025 | 0.00 |
| May 31, 2025 | 0.00 |
| Feb 28, 2025 | 0.00 |
| Nov 30, 2024 | 171.00 |
| Aug 31, 2024 | 0.00 |
| May 31, 2024 | 1,640.00 |
| Feb 29, 2024 | -47,157.00 |
| Nov 30, 2023 | 1,297.00 |
| Aug 31, 2023 | 3,711.00 |
| May 31, 2023 | 228.00 |
| Feb 28, 2023 | 49,240.00 |
| Nov 30, 2022 | 2,397.00 |
| Aug 31, 2022 | 2,836.00 |
| May 31, 2022 | 1,071.00 |
| Feb 28, 2022 | -492.00 |
| Nov 30, 2021 | -1,832.00 |
| Aug 31, 2021 | -4,500.00 |
| May 31, 2021 | 2,639.00 |
| Feb 28, 2021 | 13,883.00 |